Introduction: The prospective cohort Costa Rican Longevity and Healthy Aging Study (CRELES) offers comprehensive data on the lifestyle of elderly Costa Ricans enrolled in 2005, with survival status up to 2019. We aimed to describe the characteristics of the participants based on the number of controlled cardiovascular risk factors (CVRFs).
Methodology: We recruited 1943 participants and categorized the number of CVRFs meeting targets from 0 to 5 (A1c, blood pressure, exercise, BMI, and smoking). Descriptively, we report proportions and means with SD for each variable categorized according to the number of controlled CVRFs. We used ANOVA for continuous and chi-square tests for categorical variables to establish differences between groups.
Results: The distribution of CVRFs varied among participants, with 35.8% successfully managing three CVRFs. Notably, only 3.0% of participants attained control over all five CVRFs. The global prevalence of diabetes was 20.3%, exhibiting variations between groups. The mortality rate for all participants was 51.1% (see Table 1).
Conclusions: The categorization of participants based on the number of CVRFs highlights variations in sociodemographic and clinical parameters across different subgroups. This stratification allows a better understanding of the cohort’s distribution of risk factors in the elderly.
J. Calvo Marin: Speaker's Bureau; Novo Nordisk, AstraZeneca. G. Torrealba-Acosta: None. K. Ernest-Suarez: Advisory Panel; Janssen Pharmaceuticals, Inc. Consultant; Janssen Pharmaceuticals, Inc. Speaker's Bureau; Janssen Pharmaceuticals, Inc. Advisory Panel; Pfizer Inc. Speaker's Bureau; Pfizer Inc. Advisory Panel; AstraZeneca. Consultant; AstraZeneca. Speaker's Bureau; AstraZeneca. Advisory Panel; Takeda Canada. Speaker's Bureau; Sandoz.
